nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—Benzphetamine—obesity	0.408	1	CrCtD
Toremifene—ESR1—obesity	0.132	1	CbGaD
Toremifene—Naftifine—Benzphetamine—obesity	0.0334	0.147	CrCrCtD
Toremifene—Tamoxifen—Benzphetamine—obesity	0.0277	0.122	CrCrCtD
Toremifene—Doxylamine—Benzphetamine—obesity	0.0232	0.102	CrCrCtD
Toremifene—Dextropropoxyphene—Benzphetamine—obesity	0.022	0.0972	CrCrCtD
Toremifene—Phenoxybenzamine—Benzphetamine—obesity	0.022	0.0972	CrCrCtD
Toremifene—CYP1A2—Phentermine—obesity	0.0213	0.153	CbGbCtD
Toremifene—CYP1A2—Phenylpropanolamine—obesity	0.0204	0.146	CbGbCtD
Toremifene—Bromodiphenhydramine—Benzphetamine—obesity	0.0196	0.0865	CrCrCtD
Toremifene—Benzphetamine—Methamphetamine—obesity	0.0194	0.0857	CrCrCtD
Toremifene—CYP1A2—Bupropion—obesity	0.0182	0.13	CbGbCtD
Toremifene—Clofedanol—Benzphetamine—obesity	0.0159	0.0702	CrCrCtD
Toremifene—Orphenadrine—Benzphetamine—obesity	0.0154	0.068	CrCrCtD
Toremifene—CYP3A4—Sibutramine—obesity	0.0148	0.106	CbGbCtD
Toremifene—Benzyl Benzoate—Benzphetamine—obesity	0.0143	0.063	CrCrCtD
Toremifene—Diphenhydramine—Benzphetamine—obesity	0.0137	0.0604	CrCrCtD
Toremifene—CYP1A2—Cimetidine—obesity	0.0133	0.0954	CbGbCtD
Toremifene—ABCB1—Cimetidine—obesity	0.0117	0.0835	CbGbCtD
Toremifene—CYP3A4—Benzphetamine—obesity	0.0112	0.0801	CbGbCtD
Toremifene—CYP3A4—Bupropion—obesity	0.00951	0.0681	CbGbCtD
Toremifene—CYP3A4—Orlistat—obesity	0.00775	0.0555	CbGbCtD
Toremifene—CYP3A4—Cimetidine—obesity	0.00698	0.05	CbGbCtD
Toremifene—CYP3A4—Topiramate—obesity	0.00457	0.0327	CbGbCtD
Toremifene—ESR1—ovarian follicle—obesity	0.00234	0.331	CbGeAlD
Toremifene—ESR1—hindbrain—obesity	0.000505	0.0715	CbGeAlD
Toremifene—ESR1—respiratory system—obesity	0.000309	0.0437	CbGeAlD
Toremifene—Insomnia—Phendimetrazine—obesity	0.000273	0.00543	CcSEcCtD
Toremifene—Coordination abnormal—Bupropion—obesity	0.000271	0.0054	CcSEcCtD
Toremifene—Arrhythmia—Diethylpropion—obesity	0.00027	0.00537	CcSEcCtD
Toremifene—Alopecia—Diethylpropion—obesity	0.000267	0.00531	CcSEcCtD
Toremifene—Abnormal vision—Sibutramine—obesity	0.000267	0.00531	CcSEcCtD
Toremifene—Hepatocellular injury—Bupropion—obesity	0.000266	0.0053	CcSEcCtD
Toremifene—Pulmonary embolism—Bupropion—obesity	0.000266	0.0053	CcSEcCtD
Toremifene—Embolism—Topiramate—obesity	0.000264	0.00526	CcSEcCtD
Toremifene—Decreased appetite—Phendimetrazine—obesity	0.000262	0.00522	CcSEcCtD
Toremifene—Constipation—Phendimetrazine—obesity	0.000258	0.00513	CcSEcCtD
Toremifene—Chest pain—Phentermine—obesity	0.000257	0.00512	CcSEcCtD
Toremifene—Alopecia—Cimetidine—obesity	0.000254	0.00505	CcSEcCtD
Toremifene—Vision blurred—Diethylpropion—obesity	0.000248	0.00493	CcSEcCtD
Toremifene—Oedema—Phentermine—obesity	0.000247	0.00491	CcSEcCtD
Toremifene—Tremor—Diethylpropion—obesity	0.000246	0.0049	CcSEcCtD
Toremifene—Dry eye—Bupropion—obesity	0.000246	0.0049	CcSEcCtD
Toremifene—Menopausal symptoms—Orlistat—obesity	0.000243	0.00484	CcSEcCtD
Toremifene—CYP1A2—respiratory system—obesity	0.000238	0.0337	CbGeAlD
Toremifene—ESR1—cardiovascular system—obesity	0.000236	0.0334	CbGeAlD
Toremifene—Arthritis—Orlistat—obesity	0.000236	0.0047	CcSEcCtD
Toremifene—Leukopenia—Diethylpropion—obesity	0.000235	0.00468	CcSEcCtD
Toremifene—CYP1A1—respiratory system—obesity	0.000235	0.0332	CbGeAlD
Toremifene—Insomnia—Phenylpropanolamine—obesity	0.000233	0.00464	CcSEcCtD
Toremifene—Loperamide—POMC—obesity	0.000232	0.177	CrCbGaD
Toremifene—Dyspnoea—Phenylpropanolamine—obesity	0.00023	0.00457	CcSEcCtD
Toremifene—Vaginal haemorrhage—Topiramate—obesity	0.000229	0.00457	CcSEcCtD
Toremifene—Arthritis—Sibutramine—obesity	0.000228	0.00454	CcSEcCtD
Toremifene—Dizziness—Methamphetamine—obesity	0.000227	0.00452	CcSEcCtD
Toremifene—Glaucoma—Topiramate—obesity	0.000225	0.00449	CcSEcCtD
Toremifene—Leukopenia—Cimetidine—obesity	0.000224	0.00446	CcSEcCtD
Toremifene—Chest pain—Diethylpropion—obesity	0.000224	0.00445	CcSEcCtD
Toremifene—Insomnia—Phentermine—obesity	0.000223	0.00444	CcSEcCtD
Toremifene—Constipation—Phenylpropanolamine—obesity	0.00022	0.00439	CcSEcCtD
Toremifene—Dizziness—Benzphetamine—obesity	0.000219	0.00436	CcSEcCtD
Toremifene—Affect lability—Sibutramine—obesity	0.000218	0.00435	CcSEcCtD
Toremifene—Headache—Methamphetamine—obesity	0.000215	0.00428	CcSEcCtD
Toremifene—Gastrointestinal disorder—Phentermine—obesity	0.000213	0.00424	CcSEcCtD
Toremifene—Fatigue—Phentermine—obesity	0.000213	0.00423	CcSEcCtD
Toremifene—Constipation—Phentermine—obesity	0.000211	0.0042	CcSEcCtD
Toremifene—Mood swings—Sibutramine—obesity	0.00021	0.00418	CcSEcCtD
Toremifene—ESR1—pituitary gland—obesity	0.000209	0.0296	CbGeAlD
Toremifene—Ataxia—Sibutramine—obesity	0.000209	0.00415	CcSEcCtD
Toremifene—ESR1—adipose tissue—obesity	0.000208	0.0295	CbGeAlD
Toremifene—Rigors—Topiramate—obesity	0.000208	0.00414	CcSEcCtD
Toremifene—Hyperhidrosis—Diethylpropion—obesity	0.000207	0.00413	CcSEcCtD
Toremifene—Headache—Benzphetamine—obesity	0.000207	0.00413	CcSEcCtD
Toremifene—Breast disorder—Orlistat—obesity	0.000207	0.00412	CcSEcCtD
Toremifene—Hot flush—Bupropion—obesity	0.000207	0.00412	CcSEcCtD
Toremifene—Menopausal symptoms—Bupropion—obesity	0.000205	0.00408	CcSEcCtD
Toremifene—Liver function test abnormal—Sibutramine—obesity	0.000205	0.00408	CcSEcCtD
Toremifene—Thrombocytopenia—Cimetidine—obesity	0.0002	0.00398	CcSEcCtD
Toremifene—Dizziness—Phendimetrazine—obesity	0.000199	0.00397	CcSEcCtD
Toremifene—Arthritis—Bupropion—obesity	0.000199	0.00396	CcSEcCtD
Toremifene—Lethargy—Bupropion—obesity	0.000197	0.00393	CcSEcCtD
Toremifene—Nausea—Benzphetamine—obesity	0.000197	0.00391	CcSEcCtD
Toremifene—ESR1—digestive system—obesity	0.000196	0.0278	CbGeAlD
Toremifene—Insomnia—Diethylpropion—obesity	0.000194	0.00386	CcSEcCtD
Toremifene—Diplopia—Bupropion—obesity	0.000193	0.00385	CcSEcCtD
Toremifene—Dyspnoea—Diethylpropion—obesity	0.000191	0.00381	CcSEcCtD
Toremifene—Affect lability—Bupropion—obesity	0.00019	0.00379	CcSEcCtD
Toremifene—Musculoskeletal stiffness—Topiramate—obesity	0.000189	0.00377	CcSEcCtD
Toremifene—Headache—Phendimetrazine—obesity	0.000189	0.00376	CcSEcCtD
Toremifene—Skin discolouration—Topiramate—obesity	0.000188	0.00374	CcSEcCtD
Toremifene—ESR1—adrenal gland—obesity	0.000187	0.0265	CbGeAlD
Toremifene—Angina pectoris—Sibutramine—obesity	0.000187	0.00372	CcSEcCtD
Toremifene—Tamoxifen—CES1—obesity	0.000187	0.143	CrCbGaD
Toremifene—Gastrointestinal disorder—Diethylpropion—obesity	0.000185	0.00369	CcSEcCtD
Toremifene—Constipation—Diethylpropion—obesity	0.000183	0.00365	CcSEcCtD
Toremifene—Mood swings—Bupropion—obesity	0.000183	0.00365	CcSEcCtD
Toremifene—Ataxia—Bupropion—obesity	0.000182	0.00362	CcSEcCtD
Toremifene—Nausea—Phendimetrazine—obesity	0.000179	0.00357	CcSEcCtD
Toremifene—Asthenia—Phentermine—obesity	0.000177	0.00352	CcSEcCtD
Toremifene—Fatigue—Cimetidine—obesity	0.000176	0.0035	CcSEcCtD
Toremifene—Breast disorder—Bupropion—obesity	0.000175	0.00348	CcSEcCtD
Toremifene—Constipation—Cimetidine—obesity	0.000175	0.00347	CcSEcCtD
Toremifene—Weight increased—Sibutramine—obesity	0.000174	0.00347	CcSEcCtD
Toremifene—Neuropathy peripheral—Orlistat—obesity	0.000173	0.00345	CcSEcCtD
Toremifene—Coordination abnormal—Topiramate—obesity	0.000173	0.00344	CcSEcCtD
Toremifene—Dizziness—Phenylpropanolamine—obesity	0.00017	0.00339	CcSEcCtD
Toremifene—Pulmonary embolism—Topiramate—obesity	0.00017	0.00338	CcSEcCtD
Toremifene—Acute coronary syndrome—Sibutramine—obesity	0.000169	0.00336	CcSEcCtD
Toremifene—Neuropathy peripheral—Sibutramine—obesity	0.000168	0.00334	CcSEcCtD
Toremifene—Myocardial infarction—Sibutramine—obesity	0.000168	0.00334	CcSEcCtD
Toremifene—Hepatobiliary disease—Orlistat—obesity	0.000167	0.00333	CcSEcCtD
Toremifene—Sweating—Sibutramine—obesity	0.000164	0.00326	CcSEcCtD
Toremifene—Vomiting—Phenylpropanolamine—obesity	0.000164	0.00326	CcSEcCtD
Toremifene—Dizziness—Phentermine—obesity	0.000163	0.00325	CcSEcCtD
Toremifene—Rash—Phenylpropanolamine—obesity	0.000162	0.00323	CcSEcCtD
Toremifene—Dermatitis—Phenylpropanolamine—obesity	0.000162	0.00323	CcSEcCtD
Toremifene—ESR1—endocrine gland—obesity	0.000162	0.0229	CbGeAlD
Toremifene—CYP1A1—adipose tissue—obesity	0.000158	0.0224	CbGeAlD
Toremifene—Dry eye—Topiramate—obesity	0.000157	0.00312	CcSEcCtD
Toremifene—Vomiting—Phentermine—obesity	0.000157	0.00312	CcSEcCtD
Toremifene—Rash—Phentermine—obesity	0.000155	0.00309	CcSEcCtD
Toremifene—Dermatitis—Phentermine—obesity	0.000155	0.00309	CcSEcCtD
Toremifene—Headache—Phentermine—obesity	0.000154	0.00307	CcSEcCtD
Toremifene—Nausea—Phenylpropanolamine—obesity	0.000153	0.00305	CcSEcCtD
Toremifene—Weight increased—Bupropion—obesity	0.000152	0.00303	CcSEcCtD
Toremifene—CYP1A2—digestive system—obesity	0.000151	0.0214	CbGeAlD
Toremifene—CYP1A1—digestive system—obesity	0.000149	0.0211	CbGeAlD
Toremifene—Abnormal vision—Topiramate—obesity	0.000148	0.00295	CcSEcCtD
Toremifene—Visual impairment—Sibutramine—obesity	0.000148	0.00294	CcSEcCtD
Toremifene—Acute coronary syndrome—Bupropion—obesity	0.000147	0.00293	CcSEcCtD
Toremifene—Nausea—Phentermine—obesity	0.000146	0.00292	CcSEcCtD
Toremifene—Asthenia—Cimetidine—obesity	0.000146	0.00292	CcSEcCtD
Toremifene—ESR1—liver—obesity	0.000146	0.0207	CbGeAlD
Toremifene—Neuropathy peripheral—Bupropion—obesity	0.000146	0.00291	CcSEcCtD
Toremifene—Myocardial infarction—Bupropion—obesity	0.000146	0.00291	CcSEcCtD
Toremifene—Jaundice—Bupropion—obesity	0.000145	0.00289	CcSEcCtD
Toremifene—Eye disorder—Sibutramine—obesity	0.000143	0.00286	CcSEcCtD
Toremifene—Ospemifene—ESR1—obesity	0.000143	0.11	CrCbGaD
Toremifene—Mediastinal disorder—Orlistat—obesity	0.000143	0.00285	CcSEcCtD
Toremifene—Sweating—Bupropion—obesity	0.000143	0.00284	CcSEcCtD
Toremifene—Dizziness—Diethylpropion—obesity	0.000142	0.00282	CcSEcCtD
Toremifene—Alopecia—Orlistat—obesity	0.00014	0.00279	CcSEcCtD
Toremifene—Angiopathy—Sibutramine—obesity	0.000139	0.00277	CcSEcCtD
Toremifene—Mental disorder—Orlistat—obesity	0.000139	0.00277	CcSEcCtD
Toremifene—Malnutrition—Orlistat—obesity	0.000138	0.00275	CcSEcCtD
Toremifene—Chills—Sibutramine—obesity	0.000138	0.00274	CcSEcCtD
Toremifene—Arrhythmia—Sibutramine—obesity	0.000137	0.00273	CcSEcCtD
Toremifene—Vomiting—Diethylpropion—obesity	0.000136	0.00271	CcSEcCtD
Toremifene—Alopecia—Sibutramine—obesity	0.000136	0.0027	CcSEcCtD
Toremifene—Rash—Diethylpropion—obesity	0.000135	0.00269	CcSEcCtD
Toremifene—Dermatitis—Diethylpropion—obesity	0.000135	0.00269	CcSEcCtD
Toremifene—Dizziness—Cimetidine—obesity	0.000135	0.00269	CcSEcCtD
Toremifene—Headache—Diethylpropion—obesity	0.000134	0.00268	CcSEcCtD
Toremifene—Malnutrition—Sibutramine—obesity	0.000134	0.00266	CcSEcCtD
Toremifene—Back pain—Orlistat—obesity	0.000134	0.00266	CcSEcCtD
Toremifene—Hot flush—Topiramate—obesity	0.000132	0.00262	CcSEcCtD
Toremifene—Menopausal symptoms—Topiramate—obesity	0.000131	0.0026	CcSEcCtD
Toremifene—Vision blurred—Orlistat—obesity	0.00013	0.00259	CcSEcCtD
Toremifene—Vomiting—Cimetidine—obesity	0.00013	0.00258	CcSEcCtD
Toremifene—Back pain—Sibutramine—obesity	0.000129	0.00257	CcSEcCtD
Toremifene—ABCB1—islet of Langerhans—obesity	0.000129	0.0183	CbGeAlD
Toremifene—Visual impairment—Bupropion—obesity	0.000129	0.00257	CcSEcCtD
Toremifene—Rash—Cimetidine—obesity	0.000129	0.00256	CcSEcCtD
Toremifene—Dermatitis—Cimetidine—obesity	0.000129	0.00256	CcSEcCtD
Toremifene—Headache—Cimetidine—obesity	0.000128	0.00255	CcSEcCtD
Toremifene—Nausea—Diethylpropion—obesity	0.000127	0.00254	CcSEcCtD
Toremifene—Vision blurred—Sibutramine—obesity	0.000126	0.00251	CcSEcCtD
Toremifene—Lethargy—Topiramate—obesity	0.000126	0.0025	CcSEcCtD
Toremifene—Tremor—Sibutramine—obesity	0.000125	0.00249	CcSEcCtD
Toremifene—Eye disorder—Bupropion—obesity	0.000125	0.00249	CcSEcCtD
Toremifene—CYP1A2—endocrine gland—obesity	0.000125	0.0177	CbGeAlD
Toremifene—Vertigo—Orlistat—obesity	0.000124	0.00247	CcSEcCtD
Toremifene—CYP1A1—endocrine gland—obesity	0.000123	0.0174	CbGeAlD
Toremifene—Diplopia—Topiramate—obesity	0.000123	0.00245	CcSEcCtD
Toremifene—ABCB1—respiratory system—obesity	0.000122	0.0172	CbGeAlD
Toremifene—Angiopathy—Bupropion—obesity	0.000121	0.00242	CcSEcCtD
Toremifene—Affect lability—Topiramate—obesity	0.000121	0.00241	CcSEcCtD
Toremifene—Nausea—Cimetidine—obesity	0.000121	0.00241	CcSEcCtD
Toremifene—Mediastinal disorder—Bupropion—obesity	0.000121	0.0024	CcSEcCtD
Toremifene—Chills—Bupropion—obesity	0.00012	0.00239	CcSEcCtD
Toremifene—Vertigo—Sibutramine—obesity	0.00012	0.00239	CcSEcCtD
Toremifene—Leukopenia—Sibutramine—obesity	0.00012	0.00238	CcSEcCtD
Toremifene—Arrhythmia—Bupropion—obesity	0.00012	0.00238	CcSEcCtD
Toremifene—Alopecia—Bupropion—obesity	0.000118	0.00235	CcSEcCtD
Toremifene—Chest pain—Orlistat—obesity	0.000118	0.00234	CcSEcCtD
Toremifene—Mental disorder—Bupropion—obesity	0.000117	0.00233	CcSEcCtD
Toremifene—Mood swings—Topiramate—obesity	0.000117	0.00232	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000117	0.00232	CcSEcCtD
Toremifene—Malnutrition—Bupropion—obesity	0.000116	0.00232	CcSEcCtD
Toremifene—Ataxia—Topiramate—obesity	0.000116	0.00231	CcSEcCtD
Toremifene—Liver function test abnormal—Topiramate—obesity	0.000114	0.00226	CcSEcCtD
Toremifene—Chest pain—Sibutramine—obesity	0.000114	0.00226	CcSEcCtD
Toremifene—CYP1A2—liver—obesity	0.000113	0.0159	CbGeAlD
Toremifene—Oedema—Orlistat—obesity	0.000113	0.00224	CcSEcCtD
Toremifene—Back pain—Bupropion—obesity	0.000113	0.00224	CcSEcCtD
Toremifene—Breast disorder—Topiramate—obesity	0.000111	0.00222	CcSEcCtD
Toremifene—CYP1A1—liver—obesity	0.000111	0.0157	CbGeAlD
Toremifene—Nervous system disorder—Orlistat—obesity	0.00011	0.0022	CcSEcCtD
Toremifene—Vision blurred—Bupropion—obesity	0.00011	0.00219	CcSEcCtD
Toremifene—Clomifene—CYP19A1—obesity	0.00011	0.0838	CrCbGaD
Toremifene—CYP3A4—digestive system—obesity	0.000109	0.0155	CbGeAlD
Toremifene—Skin disorder—Orlistat—obesity	0.000109	0.00218	CcSEcCtD
Toremifene—Tremor—Bupropion—obesity	0.000109	0.00217	CcSEcCtD
Toremifene—Oedema—Sibutramine—obesity	0.000109	0.00217	CcSEcCtD
Toremifene—Hyperhidrosis—Orlistat—obesity	0.000109	0.00217	CcSEcCtD
Toremifene—Thrombocytopenia—Sibutramine—obesity	0.000107	0.00213	CcSEcCtD
Toremifene—Skin disorder—Sibutramine—obesity	0.000106	0.00211	CcSEcCtD
Toremifene—Hyperhidrosis—Sibutramine—obesity	0.000105	0.0021	CcSEcCtD
Toremifene—Vertigo—Bupropion—obesity	0.000105	0.00208	CcSEcCtD
Toremifene—Leukopenia—Bupropion—obesity	0.000104	0.00208	CcSEcCtD
Toremifene—Anorexia—Sibutramine—obesity	0.000104	0.00207	CcSEcCtD
Toremifene—Angina pectoris—Topiramate—obesity	0.000104	0.00207	CcSEcCtD
Toremifene—ABCB1—adrenal cortex—obesity	0.000102	0.0145	CbGeAlD
Toremifene—Insomnia—Orlistat—obesity	0.000102	0.00203	CcSEcCtD
Toremifene—Clomifene—ESR1—obesity	0.000101	0.0772	CrCbGaD
Toremifene—Chest pain—Bupropion—obesity	9.92e-05	0.00197	CcSEcCtD
Toremifene—Insomnia—Sibutramine—obesity	9.86e-05	0.00196	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	9.85e-05	0.00196	CcSEcCtD
Toremifene—Decreased appetite—Orlistat—obesity	9.79e-05	0.00195	CcSEcCtD
Toremifene—Gastrointestinal disorder—Orlistat—obesity	9.73e-05	0.00194	CcSEcCtD
Toremifene—Dyspnoea—Sibutramine—obesity	9.72e-05	0.00194	CcSEcCtD
Toremifene—Fatigue—Orlistat—obesity	9.71e-05	0.00193	CcSEcCtD
Toremifene—Weight increased—Topiramate—obesity	9.69e-05	0.00193	CcSEcCtD
Toremifene—Pain—Orlistat—obesity	9.63e-05	0.00192	CcSEcCtD
Toremifene—Oedema—Bupropion—obesity	9.51e-05	0.00189	CcSEcCtD
Toremifene—Decreased appetite—Sibutramine—obesity	9.48e-05	0.00189	CcSEcCtD
Toremifene—Gastrointestinal disorder—Sibutramine—obesity	9.41e-05	0.00187	CcSEcCtD
Toremifene—ABCB1—cardiovascular system—obesity	9.33e-05	0.0132	CbGeAlD
Toremifene—Constipation—Sibutramine—obesity	9.32e-05	0.00186	CcSEcCtD
Toremifene—Pain—Sibutramine—obesity	9.32e-05	0.00186	CcSEcCtD
Toremifene—Nervous system disorder—Bupropion—obesity	9.32e-05	0.00186	CcSEcCtD
Toremifene—Neuropathy peripheral—Topiramate—obesity	9.31e-05	0.00185	CcSEcCtD
Toremifene—Thrombocytopenia—Bupropion—obesity	9.31e-05	0.00185	CcSEcCtD
Toremifene—Skin disorder—Bupropion—obesity	9.23e-05	0.00184	CcSEcCtD
Toremifene—Hyperhidrosis—Bupropion—obesity	9.19e-05	0.00183	CcSEcCtD
Toremifene—Anorexia—Bupropion—obesity	9.06e-05	0.0018	CcSEcCtD
Toremifene—CYP3A4—endocrine gland—obesity	9.05e-05	0.0128	CbGeAlD
Toremifene—Insomnia—Bupropion—obesity	8.6e-05	0.00171	CcSEcCtD
Toremifene—Dyspnoea—Bupropion—obesity	8.47e-05	0.00169	CcSEcCtD
Toremifene—Phenoxybenzamine—SLC22A1—obesity	8.35e-05	0.0638	CrCbGaD
Toremifene—ABCB1—pituitary gland—obesity	8.27e-05	0.0117	CbGeAlD
Toremifene—Decreased appetite—Bupropion—obesity	8.26e-05	0.00165	CcSEcCtD
Toremifene—ABCB1—adipose tissue—obesity	8.23e-05	0.0116	CbGeAlD
Toremifene—Visual impairment—Topiramate—obesity	8.21e-05	0.00164	CcSEcCtD
Toremifene—Gastrointestinal disorder—Bupropion—obesity	8.21e-05	0.00163	CcSEcCtD
Toremifene—Fatigue—Bupropion—obesity	8.2e-05	0.00163	CcSEcCtD
Toremifene—Clomifene—CYP2E1—obesity	8.19e-05	0.0625	CrCbGaD
Toremifene—CYP3A4—liver—obesity	8.16e-05	0.0115	CbGeAlD
Toremifene—Pain—Bupropion—obesity	8.13e-05	0.00162	CcSEcCtD
Toremifene—Constipation—Bupropion—obesity	8.13e-05	0.00162	CcSEcCtD
Toremifene—Asthenia—Orlistat—obesity	8.08e-05	0.00161	CcSEcCtD
Toremifene—Pruritus—Orlistat—obesity	7.97e-05	0.00159	CcSEcCtD
Toremifene—Eye disorder—Topiramate—obesity	7.97e-05	0.00159	CcSEcCtD
Toremifene—Asthenia—Sibutramine—obesity	7.82e-05	0.00156	CcSEcCtD
Toremifene—ABCB1—digestive system—obesity	7.75e-05	0.011	CbGeAlD
Toremifene—Angiopathy—Topiramate—obesity	7.73e-05	0.00154	CcSEcCtD
Toremifene—Pruritus—Sibutramine—obesity	7.71e-05	0.00154	CcSEcCtD
Toremifene—Mediastinal disorder—Topiramate—obesity	7.68e-05	0.00153	CcSEcCtD
Toremifene—Chills—Topiramate—obesity	7.65e-05	0.00152	CcSEcCtD
Toremifene—Tamoxifen—ESR2—obesity	7.58e-05	0.0579	CrCbGaD
Toremifene—Alopecia—Topiramate—obesity	7.53e-05	0.0015	CcSEcCtD
Toremifene—Mental disorder—Topiramate—obesity	7.47e-05	0.00149	CcSEcCtD
Toremifene—Dizziness—Orlistat—obesity	7.45e-05	0.00148	CcSEcCtD
Toremifene—Malnutrition—Topiramate—obesity	7.42e-05	0.00148	CcSEcCtD
Toremifene—ABCB1—adrenal gland—obesity	7.38e-05	0.0104	CbGeAlD
Toremifene—Dizziness—Sibutramine—obesity	7.21e-05	0.00144	CcSEcCtD
Toremifene—Back pain—Topiramate—obesity	7.18e-05	0.00143	CcSEcCtD
Toremifene—Vomiting—Orlistat—obesity	7.16e-05	0.00143	CcSEcCtD
Toremifene—Rash—Orlistat—obesity	7.1e-05	0.00141	CcSEcCtD
Toremifene—Dermatitis—Orlistat—obesity	7.1e-05	0.00141	CcSEcCtD
Toremifene—Headache—Orlistat—obesity	7.06e-05	0.00141	CcSEcCtD
Toremifene—Diphenhydramine—SLC22A1—obesity	7e-05	0.0535	CrCbGaD
Toremifene—Vision blurred—Topiramate—obesity	6.99e-05	0.00139	CcSEcCtD
Toremifene—Tremor—Topiramate—obesity	6.95e-05	0.00138	CcSEcCtD
Toremifene—Vomiting—Sibutramine—obesity	6.93e-05	0.00138	CcSEcCtD
Toremifene—Rash—Sibutramine—obesity	6.87e-05	0.00137	CcSEcCtD
Toremifene—Dermatitis—Sibutramine—obesity	6.87e-05	0.00137	CcSEcCtD
Toremifene—Headache—Sibutramine—obesity	6.83e-05	0.00136	CcSEcCtD
Toremifene—Asthenia—Bupropion—obesity	6.82e-05	0.00136	CcSEcCtD
Toremifene—Pruritus—Bupropion—obesity	6.73e-05	0.00134	CcSEcCtD
Toremifene—Nausea—Orlistat—obesity	6.69e-05	0.00133	CcSEcCtD
Toremifene—Vertigo—Topiramate—obesity	6.67e-05	0.00133	CcSEcCtD
Toremifene—Leukopenia—Topiramate—obesity	6.64e-05	0.00132	CcSEcCtD
Toremifene—Nausea—Sibutramine—obesity	6.48e-05	0.00129	CcSEcCtD
Toremifene—ABCB1—endocrine gland—obesity	6.4e-05	0.00906	CbGeAlD
Toremifene—Chest pain—Topiramate—obesity	6.32e-05	0.00126	CcSEcCtD
Toremifene—Dizziness—Bupropion—obesity	6.29e-05	0.00125	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	6.27e-05	0.00125	CcSEcCtD
Toremifene—Oedema—Topiramate—obesity	6.06e-05	0.00121	CcSEcCtD
Toremifene—Vomiting—Bupropion—obesity	6.04e-05	0.0012	CcSEcCtD
Toremifene—Rash—Bupropion—obesity	5.99e-05	0.00119	CcSEcCtD
Toremifene—Dermatitis—Bupropion—obesity	5.99e-05	0.00119	CcSEcCtD
Toremifene—Headache—Bupropion—obesity	5.95e-05	0.00119	CcSEcCtD
Toremifene—Nervous system disorder—Topiramate—obesity	5.94e-05	0.00118	CcSEcCtD
Toremifene—Thrombocytopenia—Topiramate—obesity	5.93e-05	0.00118	CcSEcCtD
Toremifene—Skin disorder—Topiramate—obesity	5.88e-05	0.00117	CcSEcCtD
Toremifene—Hyperhidrosis—Topiramate—obesity	5.85e-05	0.00117	CcSEcCtD
Toremifene—ABCB1—liver—obesity	5.77e-05	0.00817	CbGeAlD
Toremifene—Anorexia—Topiramate—obesity	5.77e-05	0.00115	CcSEcCtD
Toremifene—Nausea—Bupropion—obesity	5.65e-05	0.00112	CcSEcCtD
Toremifene—Insomnia—Topiramate—obesity	5.48e-05	0.00109	CcSEcCtD
Toremifene—Dyspnoea—Topiramate—obesity	5.4e-05	0.00107	CcSEcCtD
Toremifene—Phenoxybenzamine—ADRB2—obesity	5.33e-05	0.0407	CrCbGaD
Toremifene—Decreased appetite—Topiramate—obesity	5.26e-05	0.00105	CcSEcCtD
Toremifene—Gastrointestinal disorder—Topiramate—obesity	5.23e-05	0.00104	CcSEcCtD
Toremifene—Fatigue—Topiramate—obesity	5.22e-05	0.00104	CcSEcCtD
Toremifene—Constipation—Topiramate—obesity	5.18e-05	0.00103	CcSEcCtD
Toremifene—Pain—Topiramate—obesity	5.18e-05	0.00103	CcSEcCtD
Toremifene—Tamoxifen—CYP19A1—obesity	5.07e-05	0.0387	CrCbGaD
Toremifene—Tamoxifen—ESR1—obesity	4.67e-05	0.0357	CrCbGaD
Toremifene—Asthenia—Topiramate—obesity	4.35e-05	0.000865	CcSEcCtD
Toremifene—Pruritus—Topiramate—obesity	4.28e-05	0.000853	CcSEcCtD
Toremifene—Dizziness—Topiramate—obesity	4e-05	0.000797	CcSEcCtD
Toremifene—Vomiting—Topiramate—obesity	3.85e-05	0.000767	CcSEcCtD
Toremifene—Rash—Topiramate—obesity	3.82e-05	0.00076	CcSEcCtD
Toremifene—Dermatitis—Topiramate—obesity	3.81e-05	0.00076	CcSEcCtD
Toremifene—Headache—Topiramate—obesity	3.79e-05	0.000755	CcSEcCtD
Toremifene—Tamoxifen—CYP2E1—obesity	3.78e-05	0.0289	CrCbGaD
Toremifene—Orphenadrine—CYP2E1—obesity	3.67e-05	0.0281	CrCbGaD
Toremifene—Nausea—Topiramate—obesity	3.6e-05	0.000716	CcSEcCtD
Toremifene—CYP1A1—Metabolism—STK11—obesity	3.07e-06	8.98e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP19A1—obesity	3.07e-06	8.98e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—UCP2—obesity	3.06e-06	8.94e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—UCP3—obesity	3.06e-06	8.94e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HSD11B1—obesity	3.06e-06	8.94e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ECHS1—obesity	3.06e-06	8.94e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—obesity	3.05e-06	8.91e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—obesity	3.04e-06	8.89e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ADH1B—obesity	3.01e-06	8.8e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SREBF1—obesity	3.01e-06	8.79e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SULT2A1—obesity	3.01e-06	8.78e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GLP1R—obesity	3.01e-06	8.78e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PRKCD—obesity	2.98e-06	8.71e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARGC1B—obesity	2.96e-06	8.66e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GPAM—obesity	2.96e-06	8.66e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ACSL1—obesity	2.96e-06	8.66e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—DPYD—obesity	2.96e-06	8.64e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GOT2—obesity	2.93e-06	8.55e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HTR2A—obesity	2.92e-06	8.53e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—C3—obesity	2.91e-06	8.51e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PCK1—obesity	2.88e-06	8.41e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HADH—obesity	2.88e-06	8.41e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—FADS1—obesity	2.88e-06	8.41e-05	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—ALB—obesity	2.87e-06	8.39e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—FASN—obesity	2.87e-06	8.37e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—COMT—obesity	2.86e-06	8.34e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—BCHE—obesity	2.85e-06	8.34e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PRKAR2B—obesity	2.85e-06	8.32e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—DCN—obesity	2.83e-06	8.26e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARGC1A—obesity	2.82e-06	8.23e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GNB3—obesity	2.82e-06	8.23e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HMOX1—obesity	2.8e-06	8.19e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ACP5—obesity	2.8e-06	8.18e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	2.78e-06	8.11e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IRS2—obesity	2.77e-06	8.1e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AGT—obesity	2.77e-06	8.09e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP2E1—obesity	2.75e-06	8.04e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CPT1A—obesity	2.75e-06	8.03e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GNAS—obesity	2.74e-06	8.01e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—G6PD—obesity	2.73e-06	7.97e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NQO1—obesity	2.72e-06	7.95e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LEP—obesity	2.71e-06	7.93e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOE—obesity	2.71e-06	7.93e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NAMPT—obesity	2.7e-06	7.88e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SREBF2—obesity	2.69e-06	7.87e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HK1—obesity	2.69e-06	7.87e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CAV1—obesity	2.69e-06	7.85e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOB—obesity	2.69e-06	7.85e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOA1—obesity	2.68e-06	7.84e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—obesity	2.68e-06	7.83e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GCK—obesity	2.68e-06	7.83e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LIPC—obesity	2.68e-06	7.83e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOC3—obesity	2.66e-06	7.78e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—POMC—obesity	2.64e-06	7.72e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GCG—obesity	2.61e-06	7.62e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC2A4—obesity	2.61e-06	7.62e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LPA—obesity	2.6e-06	7.6e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CETP—obesity	2.58e-06	7.55e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYCS—obesity	2.58e-06	7.53e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—LPL—obesity	2.56e-06	7.49e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—F2—obesity	2.56e-06	7.47e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PRKCB—obesity	2.56e-06	7.47e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SDC1—obesity	2.56e-06	7.47e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LPIN1—obesity	2.55e-06	7.44e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—BAD—obesity	2.53e-06	7.39e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GGT1—obesity	2.53e-06	7.38e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GOT1—obesity	2.53e-06	7.38e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKR1C3—obesity	2.51e-06	7.35e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GPX1—obesity	2.5e-06	7.31e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOA5—obesity	2.5e-06	7.29e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NCOA1—obesity	2.49e-06	7.27e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SCARB1—obesity	2.48e-06	7.23e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—STK11—obesity	2.45e-06	7.17e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP19A1—obesity	2.45e-06	7.17e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CG—obesity	2.45e-06	7.15e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	2.44e-06	7.13e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CD36—obesity	2.44e-06	7.12e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IRS1—obesity	2.42e-06	7.07e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	2.41e-06	7.04e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SREBF1—obesity	2.4e-06	7.02e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CLOCK—obesity	2.38e-06	6.95e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC22A1—obesity	2.38e-06	6.95e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GOT2—obesity	2.34e-06	6.83e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—POMC—obesity	2.33e-06	6.81e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SULT2A1—obesity	2.32e-06	6.78e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GLP1R—obesity	2.32e-06	6.78e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—INS—obesity	2.32e-06	6.77e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MTHFR—obesity	2.31e-06	6.74e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	2.31e-06	6.74e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—FASN—obesity	2.29e-06	6.68e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—DPYD—obesity	2.28e-06	6.67e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—COMT—obesity	2.28e-06	6.66e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCL2—obesity	2.28e-06	6.66e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—BCHE—obesity	2.28e-06	6.66e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARA—obesity	2.26e-06	6.62e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARGC1A—obesity	2.25e-06	6.57e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GNB3—obesity	2.25e-06	6.57e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF1—obesity	2.24e-06	6.55e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT2—obesity	2.24e-06	6.54e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HMOX1—obesity	2.24e-06	6.54e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP2E1—obesity	2.2e-06	6.42e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PRKAR2B—obesity	2.2e-06	6.42e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AGT—obesity	2.19e-06	6.41e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GNAS—obesity	2.19e-06	6.4e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—DCN—obesity	2.18e-06	6.37e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NQO1—obesity	2.17e-06	6.35e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CD—obesity	2.15e-06	6.29e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOE—obesity	2.15e-06	6.28e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOB—obesity	2.14e-06	6.27e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CAV1—obesity	2.13e-06	6.22e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SERPINE1—obesity	2.13e-06	6.22e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.13e-06	6.22e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOA1—obesity	2.12e-06	6.21e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CPT1A—obesity	2.12e-06	6.2e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.11e-06	6.16e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC2A4—obesity	2.08e-06	6.09e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GCG—obesity	2.08e-06	6.09e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NAMPT—obesity	2.08e-06	6.08e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MYC—obesity	2.07e-06	6.05e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TYK2—obesity	2.07e-06	6.05e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LIPC—obesity	2.07e-06	6.04e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GCK—obesity	2.07e-06	6.04e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYCS—obesity	2.06e-06	6.01e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOC3—obesity	2.05e-06	6e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RHOA—obesity	2.05e-06	6e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—LPL—obesity	2.05e-06	5.98e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.03e-06	5.94e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3R1—obesity	2.03e-06	5.94e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOS3—obesity	2.03e-06	5.94e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GGT1—obesity	2.02e-06	5.9e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GOT1—obesity	2.02e-06	5.9e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GPX1—obesity	2e-06	5.84e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CETP—obesity	1.99e-06	5.83e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NCOA1—obesity	1.99e-06	5.81e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SDC1—obesity	1.97e-06	5.76e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP19A1—obesity	1.96e-06	5.72e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—STK11—obesity	1.96e-06	5.72e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CD36—obesity	1.95e-06	5.68e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKR1C3—obesity	1.94e-06	5.67e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CG—obesity	1.94e-06	5.67e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SCARB1—obesity	1.91e-06	5.58e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MTOR—obesity	1.88e-06	5.48e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CB—obesity	1.88e-06	5.48e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARG—obesity	1.87e-06	5.47e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SREBF1—obesity	1.85e-06	5.42e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—POMC—obesity	1.85e-06	5.39e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MTHFR—obesity	1.84e-06	5.39e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—INS—obesity	1.84e-06	5.36e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—COMT—obesity	1.82e-06	5.32e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARA—obesity	1.81e-06	5.29e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GOT2—obesity	1.8e-06	5.27e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARGC1A—obesity	1.8e-06	5.25e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GNB3—obesity	1.8e-06	5.25e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HMOX1—obesity	1.79e-06	5.22e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—FASN—obesity	1.77e-06	5.16e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—BCHE—obesity	1.76e-06	5.14e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AGT—obesity	1.75e-06	5.12e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GNAS—obesity	1.75e-06	5.11e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOE—obesity	1.72e-06	5.02e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOB—obesity	1.71e-06	5e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CD—obesity	1.71e-06	4.98e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CAV1—obesity	1.7e-06	4.97e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOA1—obesity	1.7e-06	4.96e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP2E1—obesity	1.7e-06	4.96e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALB—obesity	1.68e-06	4.92e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NQO1—obesity	1.68e-06	4.9e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LPL—obesity	1.63e-06	4.78e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MMP9—obesity	1.63e-06	4.76e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3R1—obesity	1.61e-06	4.7e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NOS3—obesity	1.61e-06	4.7e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GCG—obesity	1.61e-06	4.7e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC2A4—obesity	1.61e-06	4.7e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GPX1—obesity	1.6e-06	4.66e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYCS—obesity	1.59e-06	4.64e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK8—obesity	1.59e-06	4.63e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GGT1—obesity	1.56e-06	4.55e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GOT1—obesity	1.56e-06	4.55e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CD36—obesity	1.55e-06	4.54e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CG—obesity	1.55e-06	4.53e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NCOA1—obesity	1.53e-06	4.48e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP19A1—obesity	1.51e-06	4.42e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—STK11—obesity	1.51e-06	4.42e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARG—obesity	1.5e-06	4.37e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CB—obesity	1.49e-06	4.34e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—POMC—obesity	1.47e-06	4.31e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS2—obesity	1.47e-06	4.3e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MTHFR—obesity	1.47e-06	4.3e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—INS—obesity	1.47e-06	4.28e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STAT3—obesity	1.45e-06	4.24e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARA—obesity	1.44e-06	4.22e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—AKT1—obesity	1.44e-06	4.2e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—COMT—obesity	1.41e-06	4.11e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AGT—obesity	1.4e-06	4.09e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARGC1A—obesity	1.39e-06	4.05e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GNB3—obesity	1.39e-06	4.05e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HMOX1—obesity	1.38e-06	4.03e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOE—obesity	1.37e-06	4e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CD—obesity	1.36e-06	3.98e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CAV1—obesity	1.36e-06	3.97e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOA1—obesity	1.35e-06	3.96e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GNAS—obesity	1.35e-06	3.94e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MYC—obesity	1.35e-06	3.94e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALB—obesity	1.34e-06	3.93e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TGFB1—obesity	1.34e-06	3.93e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOB—obesity	1.32e-06	3.86e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.3e-06	3.79e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3R1—obesity	1.29e-06	3.76e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NOS3—obesity	1.29e-06	3.76e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LPL—obesity	1.26e-06	3.69e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CG—obesity	1.24e-06	3.61e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GPX1—obesity	1.23e-06	3.6e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CD36—obesity	1.2e-06	3.5e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARG—obesity	1.19e-06	3.49e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CB—obesity	1.19e-06	3.47e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—POMC—obesity	1.18e-06	3.44e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS2—obesity	1.18e-06	3.44e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—INS—obesity	1.17e-06	3.42e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CA—obesity	1.14e-06	3.34e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTHFR—obesity	1.14e-06	3.32e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARA—obesity	1.11e-06	3.26e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CD—obesity	1.09e-06	3.18e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AGT—obesity	1.08e-06	3.15e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALB—obesity	1.07e-06	3.14e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOE—obesity	1.06e-06	3.09e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CAV1—obesity	1.05e-06	3.06e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOA1—obesity	1.05e-06	3.05e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3R1—obesity	1.03e-06	3e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NOS3—obesity	1.03e-06	3e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6—obesity	1.01e-06	2.96e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CG—obesity	9.54e-07	2.79e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CB—obesity	9.48e-07	2.77e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS2—obesity	9.39e-07	2.74e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT1—obesity	9.34e-07	2.73e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARG—obesity	9.21e-07	2.69e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—POMC—obesity	9.09e-07	2.65e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CA—obesity	9.06e-07	2.65e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—INS—obesity	9.04e-07	2.64e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CD—obesity	8.39e-07	2.45e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALB—obesity	8.28e-07	2.42e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3R1—obesity	7.92e-07	2.31e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NOS3—obesity	7.92e-07	2.31e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKT1—obesity	7.4e-07	2.16e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CB—obesity	7.31e-07	2.14e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS2—obesity	7.25e-07	2.12e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CA—obesity	7.24e-07	2.11e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKT1—obesity	5.91e-07	1.73e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CA—obesity	5.78e-07	1.69e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKT1—obesity	4.72e-07	1.38e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CA—obesity	4.46e-07	1.3e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKT1—obesity	3.64e-07	1.06e-05	CbGpPWpGaD
